TearLab Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.24 |
Market Cap |
$975.76 K |
Shares Outstanding |
12.2 M |
Public Float |
10.94 M |
Address |
150 LaTerraza Boulevard Escondido California 92121 United States |
Employees | - |
Website | http://www.tearlab.com |
Updated | 07/08/2019 |
TearLab Corp. engages in the development and marketing of lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by testing disease markers in tears at the point-of-care. It also intends to measure the osmolarity of human tears to aid in the diagnosis of dry eye disease in patients suspected of having dry eye disease. The company was founded by Benjamin D. |